GlassScriptPhysician profile
Fahad Javed
NPI 1033425087
$7,716.07
in general payments reported to CMS, 2019-2025
20 companies · $355 in 2025
The $355 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,364 · 2020: $1,056 · 2021: $2,763 · 2022: $297 · 2023: $556 · 2024: $325 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,236.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,389.52 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Venaseal |
| W. L. Gore & Associates, INC. | $2,154.75 | 2019-2024 | Gore Cardioform Septal Occluder |
| Medtronic Vascular, INC. | $1,012.41 | 2020 | |
| Abbott Laboratories | $361.07 | 2019-2025 | Diamondback Coronary, Cardiomems |
| Biotronik INC. | $308.78 | 2022-2024 | Acticor 7 Vr-T Dx, Rivacor 7 Dr-T, Edora 8 Dr-T |
| Siemens Medical Solutions USA, INC. | $234.78 | 2021-2022 | |
| Boston Scientific Corporation | $229.73 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $211.62 | 2020-2025 | Lifevest |
| Abiomed | $193.99 | 2019-2025 | |
| Amgen INC. | $159.57 | 2019-2023 | Repatha |
| Edwards Lifesciences Corporation | $146.06 | 2023 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $127.52 | 2021-2023 | Camzyos |
| Novartis Pharmaceuticals Corporation | $60.66 | 2023-2025 | |
| Tactile Systems Technology INC | $26.16 | 2023 | Flexitouch Plus, Entre Plus |
| Bard Peripheral Vascular, INC. | $19.95 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $18.46 | 2023 | Zilver Ptx |
| Baxter Healthcare | $15.97 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $15.82 | 2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $15.74 | 2019 | |
| Pfizer INC. | $13.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fahad Javed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.